Charles River–JPMorgan Chase: investor conference, 201701 supply service Charles River presents at JP Morgan Healthcare Conference 2017

	Period	2017-01-10
	Region	San Francisco, CA
	Country	United States (USA)
	Successor	Charles River–JPMorgan Chase: investor conference, 201801 supply service Charles River presents at JP Morgan Healthcare Conference 2018
	Partner, 1st	Charles River Laboratories International Inc. (NYSE: CRL)
	Group	Charles River (Group)
	Partner, 2nd	J.P. Morgan Securities LLC
	Group	JPMorgan Chase (Group)
	Product	J.P. Morgan 35th Annual Healthcare Conference 2017 San Francisco
	Product 2	drug development services
	Person	Hardy, Susan E. (Charles River 201701 VP Investor Relations)

Charles River Laboratories International, Inc.. (1/9/17). "Press Release: Charles River Laboratories to Present at J.P. Morgan Healthcare Conference". Wilmington, MA.

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 10th, at 1:30 p.m. PST (4:30 p.m. EST), followed by a question and answer session at 2:00 p.m. PST (5:00 p.m. EST). Management will present an overview of Charles River’s strategic focus, business developments, and recent trends.

A live webcast of the presentation and the subsequent question and answer session will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website approximately three hours after the presentation and will remain available for approximately two weeks.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Charles River Laboratories International, Inc.
Susan E. Hardy, 781-222-6190
Corporate Vice President, Investor Relations
susan.hardy@crl.com